Copyright Reports & Markets. All rights reserved.

Global Small Molecule Anti-tumor Targted Drug Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 EGFR
    • 1.2.3 ALK
    • 1.2.4 Bcr-Abl
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2020 VS 2026
    • 1.3.2 Liver Cancer
    • 1.3.3 Colorectal Cancer
    • 1.3.4 Lung Cancer
    • 1.3.5 Gastric Cancer
    • 1.3.6 Breast Cancer
    • 1.3.7 Esophageal Cancer
    • 1.3.8 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Small Molecule Anti-tumor Targted Drug Market Perspective (2015-2026)
  • 2.2 Global Small Molecule Anti-tumor Targted Drug Growth Trends by Regions
    • 2.2.1 Small Molecule Anti-tumor Targted Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Small Molecule Anti-tumor Targted Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Market Size
    • 3.1.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2015-2020)
  • 3.2 Global Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Small Molecule Anti-tumor Targted Drug Revenue
  • 3.4 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio
    • 3.4.1 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Anti-tumor Targted Drug Revenue in 2019
  • 3.5 Key Players Small Molecule Anti-tumor Targted Drug Area Served
  • 3.6 Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
  • 3.7 Date of Enter into Small Molecule Anti-tumor Targted Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Anti-tumor Targted Drug Breakdown Data by Type (2015-2026)

  • 4.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2021-2026)

5 Small Molecule Anti-tumor Targted Drug Breakdown Data by Application (2015-2026)

  • 5.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2015-2020)
  • 5.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2015-2026)
  • 6.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020)
  • 6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020)
  • 6.4 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size (2015-2026)
  • 7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020)
  • 7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020)
  • 7.4 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Small Molecule Anti-tumor Targted Drug Market Size (2015-2026)
  • 8.2 China Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020)
  • 8.3 China Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020)
  • 8.4 China Small Molecule Anti-tumor Targted Drug Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Small Molecule Anti-tumor Targted Drug Market Size (2015-2026)
  • 9.2 Japan Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020)
  • 9.3 Japan Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020)
  • 9.4 Japan Small Molecule Anti-tumor Targted Drug Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size (2015-2026)
  • 10.2 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Astrazeneca
    • 11.1.1 Astrazeneca Company Details
    • 11.1.2 Astrazeneca Business Overview
    • 11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Introduction
    • 11.1.4 Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020))
    • 11.1.5 Astrazeneca Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Introduction
    • 11.2.4 Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.2.5 Novartis Recent Development
  • 11.3 Millennium Pharmaceuticals
    • 11.3.1 Millennium Pharmaceuticals Company Details
    • 11.3.2 Millennium Pharmaceuticals Business Overview
    • 11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Introduction
    • 11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.3.5 Millennium Pharmaceuticals Recent Development
  • 11.4 Bayer
    • 11.4.1 Bayer Company Details
    • 11.4.2 Bayer Business Overview
    • 11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Introduction
    • 11.4.4 Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.4.5 Bayer Recent Development
  • 11.5 Exelixis
    • 11.5.1 Exelixis Company Details
    • 11.5.2 Exelixis Business Overview
    • 11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Introduction
    • 11.5.4 Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.5.5 Exelixis Recent Development
  • 11.6 Abbvie
    • 11.6.1 Abbvie Company Details
    • 11.6.2 Abbvie Business Overview
    • 11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Introduction
    • 11.6.4 Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.6.5 Abbvie Recent Development
  • 11.7 Boehringer-Ingelheim
    • 11.7.1 Boehringer-Ingelheim Company Details
    • 11.7.2 Boehringer-Ingelheim Business Overview
    • 11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Introduction
    • 11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.7.5 Boehringer-Ingelheim Recent Development
  • 11.8 Eisai
    • 11.8.1 Eisai Company Details
    • 11.8.2 Eisai Business Overview
    • 11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Introduction
    • 11.8.4 Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.8.5 Eisai Recent Development
  • 11.9 Pfizer
    • 11.9.1 Pfizer Company Details
    • 11.9.2 Pfizer Business Overview
    • 11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Introduction
    • 11.9.4 Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.9.5 Pfizer Recent Development
  • 11.10 Bristol-Myers Squibb
    • 11.10.1 Bristol-Myers Squibb Company Details
    • 11.10.2 Bristol-Myers Squibb Business Overview
    • 11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Introduction
    • 11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 11.10.5 Bristol-Myers Squibb Recent Development
  • 11.11 Roche
    • 10.11.1 Roche Company Details
    • 10.11.2 Roche Business Overview
    • 10.11.3 Roche Small Molecule Anti-tumor Targted Drug Introduction
    • 10.11.4 Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 10.11.5 Roche Recent Development
  • 11.12 Bettapharma
    • 10.12.1 Bettapharma Company Details
    • 10.12.2 Bettapharma Business Overview
    • 10.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Introduction
    • 10.12.4 Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2015-2020)
    • 10.12.5 Bettapharma Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Small Molecule Anti-tumor Targted Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Anti-tumor Targted Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    EGFR
    ALK
    Bcr-Abl
    Others

    Market segment by Application, split into
    Liver Cancer
    Colorectal Cancer
    Lung Cancer
    Gastric Cancer
    Breast Cancer
    Esophageal Cancer
    Others

    Based on regional and country-level analysis, the Small Molecule Anti-tumor Targted Drug market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Small Molecule Anti-tumor Targted Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Astrazeneca
    Novartis
    Millennium Pharmaceuticals
    Bayer
    Exelixis
    Abbvie
    Boehringer-Ingelheim
    Eisai
    Pfizer
    Bristol-Myers Squibb
    Roche
    Buy now